eCite Digital Repository
Use of evidence- based therapy for the prevention of cardiovascular events among older people
Citation
Castelino, RL and Chen, TF and Guddattu, V and Bajorek, BV, Use of evidence- based therapy for the prevention of cardiovascular events among older people, Evaluation and The Health Professions, 33, (3) pp. 276-301. ISSN 0163-2787 (2006) [Refereed Article]
Copyright Statement
Copyright 2006 Sage Publications
Official URL: http://dx.doi.org/10.1177/0163278710374854
Abstract
Abstract
Evidence-based therapies (EBTs) for the prevention of cardiovascular disease
(CVD) are reportedly underutilized in older people. The primary purpose
of this study was to evaluate the use of EBTs for the prevention of
CVD events in older people and secondarily whether a Home Medicines
Review (HMR) service by pharmacists’ predicts the use of these medicines.
A retrospective cross-sectional audit of HMR reports pertaining to 608
community-dwelling older people (65 years) was conducted. EBTs considered
for this audit included four guideline-recommended therapies for
CVD: antithrombotic therapy (warfarin+antiplatelet therapy), b-blockers,
statins, and angiotensin agents (angiotensin-converting enzyme inhibitors
[ACEI]+angiotensin II receptor blockers [ARBs]). The prevalence of EBT use among the older people, mean age (SD) 75.6 (7.5) years, was: 73% for
antithrombotic therapy, 75% for statins, 74% for angiotensin therapy, and
35% for b-blockers. CVD risk factors warranting treatment with these EBTs
were frequently associated with use of EBTs. EBTs were least likely to be
used in those with coronary interventions like coronary artery bypass
grafting (CABG)/stent insertion (all EBTs except angiotensin agents) and
angiotensin agents in those with a history of myocardial infarction or
chronic heart failure. A pharmacist-led HMR service was significantly
associated with the prescribing of all 4 EBTs. The results from this study
show good adherence to evidence-based guidelines in general, although
there is still room for improvement to further optimize clinical outcomes
in these complex patients. The study also adds to the available literature
on the effectiveness of pharmacists’ collaborative contribution to the care
of these high-risk patients.
Item Details
Item Type: | Refereed Article |
---|---|
Keywords: | Evidence-based Therapies, Home Medicines, Reviews |
Research Division: | Medical and Health Sciences |
Research Group: | Pharmacology and Pharmaceutical Sciences |
Research Field: | Clinical Pharmacy and Pharmacy Practice |
Objective Division: | Health |
Objective Group: | Other Health |
Objective Field: | Health not elsewhere classified |
UTAS Author: | Castelino, RL (Dr Ronald Castelino) |
ID Code: | 86273 |
Year Published: | 2006 |
Deposited By: | Pharmacy |
Deposited On: | 2013-09-02 |
Last Modified: | 2014-04-17 |
Downloads: | 0 |
Repository Staff Only: item control page